These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22958645)

  • 21. Formulation and comparative characterization of chitosan, gelatin, and chitosan-gelatin-coated liposomes of CPT-11-HCl.
    Shende P; Gaud R
    Drug Dev Ind Pharm; 2009 May; 35(5):612-8. PubMed ID: 18951273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomal adjuvants: preparation and formulation with antigens.
    Haensler J
    Methods Mol Biol; 2010; 626():73-90. PubMed ID: 20099122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation.
    Li C; Cui J; Wang C; Li Y; Zhang L; Xiu X; Li Y; Wei N; Zhang L; Wang P
    J Pharm Pharmacol; 2011 Jun; 63(6):765-73. PubMed ID: 21585373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of liposomal encapsulation on degradation of anthocyanins of black carrot extract by adding ascorbic acid.
    Guldiken B; Gibis M; Boyacioglu D; Capanoglu E; Weiss J
    Food Funct; 2017 Mar; 8(3):1085-1093. PubMed ID: 28154868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors.
    Fang T; Dong Y; Zhang X; Xie K; Lin L; Wang H
    Int J Pharm; 2016 Oct; 512(1):39-48. PubMed ID: 27544846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pH-dependent association of SN-38 with lipid bilayers of a novel liposomal formulation.
    Peikov V; Ugwu S; Parmar M; Zhang A; Ahmad I
    Int J Pharm; 2005 Aug; 299(1-2):92-9. PubMed ID: 15996839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice.
    Atyabi F; Farkhondehfai A; Esmaeili F; Dinarvand R
    Acta Pharm; 2009 Jun; 59(2):133-44. PubMed ID: 19564139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biphasic Synthesis of Large-Pore and Well-Dispersed Benzene Bridged Mesoporous Organosilica Nanoparticles for Intracellular Protein Delivery.
    Yang Y; Niu Y; Zhang J; Meka AK; Zhang H; Xu C; Lin CX; Yu M; Yu C
    Small; 2015 Jun; 11(23):2743-9. PubMed ID: 25652950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.
    Immordino ML; Dosio F; Cattel L
    Int J Nanomedicine; 2006; 1(3):297-315. PubMed ID: 17717971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of organosilica nanoparticles with dual functional groups and simultaneous payload entrapment.
    Su YL; Lin CY; Chiu SJ; Hu TM
    J Microencapsul; 2018 Jun; 35(4):381-391. PubMed ID: 30086674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of copper gluconate/triethanolamine in irinotecan encapsulation inside the liposomes.
    Dicko A; Tardi P; Xie X; Mayer L
    Int J Pharm; 2007 Jun; 337(1-2):219-28. PubMed ID: 17270372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liposomalization of SN-38 as active metabolite of CPT-11.
    Sadzuka Y; Takabe H; Sonobe T
    J Control Release; 2005 Nov; 108(2-3):453-9. PubMed ID: 16182400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.
    Hathout RM; Mansour S; Mortada ND; Guinedi AS
    AAPS PharmSciTech; 2007 Jan; 8(1):1. PubMed ID: 17408209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin.
    Whitaker RD; Ingebrigtsen SG; Naderkhani E; Skar ML; Flaten GE
    J Liposome Res; 2013 Dec; 23(4):298-310. PubMed ID: 23763495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions.
    Zhao YX; Hua HY; Chang M; Liu WJ; Zhao Y; Liu HM
    Int J Pharm; 2010 Jun; 392(1-2):64-71. PubMed ID: 20302926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of ciprofloxacin liposomes: derivative ultraviolet spectrophotometric determinations.
    Gürsoy A; Senyücel B
    J Microencapsul; 1997; 14(6):769-76. PubMed ID: 9394258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Encapsulation of polyphenolic grape seed extract in polymer-coated liposomes.
    Gibis M; Vogt E; Weiss J
    Food Funct; 2012 Mar; 3(3):246-54. PubMed ID: 22116575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Encapsulation of calcitonin in liposomes depends on the vesicle preparation method.
    Arien A; Dupuy B
    J Microencapsul; 1997; 14(6):753-60. PubMed ID: 9394256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of liposomal formulation on the incorporation and retention of PNA oligomers.
    Ringhieri P; Avitabile C; Saviano M; Morelli G; Romanelli A; Accardo A
    Colloids Surf B Biointerfaces; 2016 Sep; 145():462-469. PubMed ID: 27236097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topotecan Liposomes: A Visit from a Molecular to a Therapeutic Platform.
    Saraf S; Jain A; Hurkat P; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2016; 33(5):401-432. PubMed ID: 27910741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.